Hepatitis B surface antigen assays : operational characteristics (phase 1) : report 1
World Health Organization. Dept. of Blood Safety and Clinical Technology. (2001). Hepatitis B surface antigen assays : operational characteristics (phase 1) : report 1. Geneva : World Health Organization. http://www.who.int/iris/handle/10665/66924
Gov't Doc #WHO/BCT/BTS/01.4
MetadataShow full item record
Showing items related by title and MeSH subject.
A collaborative study of the proposed international reference preparation for hepatitis B vaccine containing plasma-derived hepatitis B surface antigen (HBsAg / by Morag Ferguson, Valerie Seagroat and Geoffrey C. Schild Ferguson, Morag; Seagroatt, Valerie; Schild, Geoffrey Christopher; World Health Organization. Biologicals Unit (WHO/BS/86.1525, Rev.1. Unpublished, 1986)
Prevalence of hepatitis B surface antigen and hepatitis C virus antibodies among blood donors in Alexandria, Egypt Wasfi, O.A.S.; Sadek, N.A. (2011)Hepatitis B and C virus infections are common serious complications of blood transfusion. Over a 6-month period in 2007/08 all samples from a blood bank in Alexandria, Egypt [n=3420] were tested for hepatitis B surface antigen [HBsAg] and anti-hepatitis C virus [HCV] antibodies. A total of 119 donors [3.5%] were positive for anti-HCV and 47 [1.4%] for HBsAg. The mean age of HCV - positive donors was significantly higher than HBV-positive donors: 35.7 [SD 83] versus 29.9 [SD 7.4] years, HCV and HBV prevalence was highest among males [93.3% and ...